Adenotonsillectomy timing enters the orthodontic equation in childhood class II malocclusion
A new randomised trial is set to examine a question that sits at the intersection of airway medicine and orthodontics: whether the timing of adenotonsillectomy changes the effectiveness of functional jaw correction in children with class II malocclusion and mandibular retrognathia. The FACT-II protocol focuses on a clinically familiar but often underappreciated overlap. In children with obstructive sleep apnoea, enlarged adenoids and tonsils can drive chronic mouth breathing, airway crowding, and a mandibular posture that may worsen facial growth patterns over time.
The trial is built around a practical concern. A twin block appliance can guide mandibular advancement and is widely used in early orthodontic treatment, yet persistent upper airway obstruction may blunt both the response and the stability of that correction. When pharyngeal obstruction forces the mandible into a chronically retruded or rotated position, functional orthopedic treatment is no longer working against a static skeletal pattern alone. It is working against an airway-driven behavioral and growth environment that continues to shape the child’s craniofacial development.
Two treatment sequences will be compared head to head
The study uses a single-centre, parallel-group, superiority randomised controlled design at the School and Hospital of Stomatology, Wuhan University. Forty children aged 8 to 14 years will be enrolled if they have class II mandibular retrognathia, co-existing adenotonsillar hypertrophy-induced obstructive sleep apnoea, and a clinical indication for both surgery and functional orthodontic treatment. Participants will be randomised in a 1:1 ratio to one of two sequences: adenotonsillectomy followed by twin block therapy, or twin block treatment followed by adenotonsillectomy.
The design reflects a direct clinical tension. Surgeons and orthodontists frequently encounter children whose airway obstruction and malocclusion are both real, both relevant, and both potentially modifiable. The unresolved issue is sequencing. If airway obstruction is removed first, mandibular posture, sleep quality, and oral breathing habits may improve before orthodontic force is applied. If functional orthodontics begins first, treatment may proceed in a setting where the airway remains mechanically compromised.
One sequence may create a more biologically permissive environment for the other.
Airway improvement and jaw correction are the co-primary targets
The primary outcomes are the change in apnoea-hypopnoea index and the change in the point A-nasion-point B angle from baseline to postorthodontic treatment between the two groups. Those outcomes capture the dual nature of the disorder. The apnea-hypopnea index measures sleep-disordered breathing burden, while the ANB angle offers a standard craniofacial metric for sagittal jaw relationship.
In children with adenotonsillar obstruction, the airway and facial skeleton are not independent systems. Chronic mouth breathing, altered tongue posture, and compensatory head and mandibular positioning can all influence maxillofacial growth. If surgery reduces the mechanical burden on the upper airway before orthodontic treatment begins, the child may spend less time in the compensatory posture that tends to reinforce mandibular retrusion. That biological sequence makes the trial highly plausible, even before any outcomes are measured.
The protocol also plans to assess changes within each group and between groups, which should help clarify whether one treatment order produces a measurable advantage in both sleep and occlusal correction.
Dental, skeletal, airway, and quality-of-life measures will broaden the readout
Secondary outcomes extend beyond the two primary endpoints and include other dental, skeletal, upper airway, and soft tissue changes, along with subjective sleep-related and oral-related quality of life. This broader assessment matters because the benefits of airway surgery and functional appliance therapy rarely stop at a single anatomic or polysomnographic marker. Parents may notice quieter sleep, less mouth breathing, or better daytime functioning before a radiographic change becomes obvious. Orthodontic metrics may improve while the child’s sleep quality lags behind, or the reverse may occur.
The inclusion of subjective quality-of-life measures also gives the trial bedside relevance. For families, the real-world question is rarely limited to whether an angle or index changes. They want to know whether the child sleeps better, breathes more normally, and can complete orthodontic treatment with a more stable result. Those outcomes are especially important when treatment plans require both surgery and months of appliance wear.
Why the protocol matters for children with airway-driven craniofacial change
The protocol rests on a central pathophysiologic idea: persistent adenotonsillar obstruction can sustain the conditions that contribute to mandibular retrusion and clockwise mandibular rotation. In a growing child, those effects may influence not only symptoms of sleep-disordered breathing but also the mechanics of orthodontic correction. If the upper airway remains crowded, the mandible may continue to adopt a posture that counters functional advancement. If the obstruction is relieved early, the child may enter appliance therapy with improved nasal airflow, reduced mouth breathing, and less adverse postural adaptation.
That is a clinically specific hypothesis, not a broad promise. The trial does not claim the two interventions are interchangeable. It tests whether the order in which they are delivered changes the final result.
The study also has the practical limitation of being single-centre and small, with 40 participants. Even so, the design is well suited to a question that has been guided for years more by clinical logic than comparative evidence. A randomized structure is the right tool for separating airway effects from orthodontic effects when both are happening in the same child.
Trial oversight, ethics, and what the protocol can and cannot answer
Ethics approval has been granted by the Ethics Committee of the School and Hospital of Stomatology, Wuhan University under number 2022-D07. The trial is registered as ChiCTR2200061703. Findings are planned for dissemination through scientific conferences or published articles.
Because this is a protocol rather than a results paper, the study cannot yet establish whether surgery-first sequencing is superior, equivalent, or irrelevant. It also cannot determine how durable any difference may be after treatment ends. What it can do is define a rigorous framework for testing whether adenotonsillectomy before twin block therapy improves both airway physiology and skeletal correction in a pediatric population where the two problems are tightly linked.
If the study shows a meaningful divergence in sleep and jaw outcomes, it could affect how clinicians coordinate ENT and orthodontic care for children with class II malocclusion and obstructive sleep apnoea. If the sequences perform similarly, that too would be useful, because it would allow treatment planning to prioritize access, symptom burden, or surgical timing without sacrificing orthodontic goals.